• Our offerings
    • Market Access Strategy, HTA, and Health Economics
    • Nordic RWE & Evidence Generation
    • AI & Dashboard Solutions
    • Policy Shaping & Life Science Consulting
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

The Danish Medicines Council and Amgros allow companies more time to propose alternative agreements

Nordic HTA cooperation (JNHB) extended for another five years

The Danish Medicines Council reorganises its secretariat into three centres

Three questions to Anthony, Principal Consultant at NHTA!

The Danish Medicines Council issues ADHD medication guidelines for the primary healthcare sector

EMA recommends oral Wegovy for weight management

First medicine receives general reimbursement after confidential price negotiation

NICE opens routine NHS access to SMA treatments

NICE approves givinostat for Duchenne muscular dystrophy

TLV to host seminar on U.S. MFN policy

Previous 1 2 3 4 5 … 8 Next

Leveraging Nordic data & insights to support your Market Access goals.

NHTA Copenhagen
Nelson Mandelas Allé 14, 2450 Copenhagen SV, Denmark

NHTA Stockholm
Vasagatan 10, 5th floor, 111 20 Stockholm, Sweden

Contact us

+45 44 222 777
CVR: 39842882

+46 70-322 66 65
Org.nr: 559438-4207

contact@nhta.com

Navigation

  • Our offerings
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Follow us on LinkedIn

LinkedIn
  • Data Protection Policy
  • Cookie Policy